Aripiprazole for the treatment of tic disorders in children: A systematic review and meta-analysis

BMC Psychiatry

Volumn 15, Issue 1, 2015, Pages

  Yang, Chun Song ^a   Huang, Hong ^a   Zhang, Ling Li ^a   Zhu, Cai Rong ^a   Guo, Qin ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Aripiprazole; Children; Systematic review; Tic disorders

Indexed keywords

ARIPIPRAZOLE; HALOPERIDOL; PLACEBO; RISPERIDONE; TIAPRIDE; NEUROLEPTIC AGENT;

ABDOMINAL PAIN; ADULT; AKATHISIA; ANOREXIA; ANXIETY DISORDER; ARTHRALGIA; ARTICLE; BLURRED VISION; BODY WEIGHT DISORDER; CHILD; COMPARATIVE STUDY; CONSTIPATION; DECREASED APPETITE; DIZZINESS; DROWSINESS; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; DYSPEPSIA; ECG ABNORMALITY; EMOTIONAL DISORDER; EXTRAPYRAMIDAL SYMPTOM; FATIGUE; GASTROINTESTINAL SYMPTOM; HUMAN; INCREASED APPETITE; INSOMNIA; IRRITABILITY; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; META ANALYSIS; NAUSEA; NIGHTMARE; NOCTURIA; OPEN STUDY; OUTCOME ASSESSMENT; POLYDIPSIA; PRESCHOOL CHILD; PRURITUS; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; RHINOPHARYNGITIS; SCHOOL CHILD; SCORING SYSTEM; SEDATION; SYSTEMATIC REVIEW; THORAX PAIN; TIC; TREATMENT DURATION; TREATMENT RESPONSE; TREMOR; UPPER RESPIRATORY TRACT INFECTION; URINE INCONTINENCE; VOMITING; WEIGHT GAIN; XEROSTOMIA; ADOLESCENT; PROCEDURES; PSYCHOLOGY; TIC DISORDERS; TREATMENT OUTCOME;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; ARIPIPRAZOLE; CHILD; CHILD, PRESCHOOL; HALOPERIDOL; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIC DISORDERS; TREATMENT OUTCOME;

EID: 84937840415     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-015-0504-z     Document Type: Article

References (35)

1. Plessen KJ. Tic disorders and Tourette's syndrome. Eur Child Adolesc Psychiatry. 2013;22 Suppl 1:S55-60.
2. Jimenez-Shahed J. Tourette syndrome. Neurol Clin. 2009;27(3):737-55.
3. Knight T, Steeves T, Day L, Lowerison M, Jette N, Pringsheim T. Prevalence of tic disorders: a systematic review and meta-analysis. Pediatr Neurol. 2012;47(2):77-90.
4. Cavanna AE, Seri S. Tourette's syndrome. Br Med J. 2013;347:1-6.
5. Yang CS, Zhang LL, Zeng LN, Huang L, Liu YT. Topiramate for Tourette's syndrome in children: a meta-analysis. Pediatr Neurol. 2013;49(5):344-50.
6. Gilbert D, Batterson J, Sethuramamn G, Sallee F. Tic reduction with risperidone versus pimozide in a randomized double-blind cross-over trial. J Am Acad Child Adolesc Psychiatry. 2004;43:206-14.
7. Kim B, Lee B, Hwang J, Shin M, Cho S. Effectiveness and safety of risperidone for children and adolescents with chronic tic or Tourette's disorder in Korea. J Child Adolesc Psychopharmacol. 2005;15:318-24.
8. Dion Y, Annable L, Sandor P, Couinard G. Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol. 2002;22:31-9.
9. Ghanizadeh A, Haghighi A. Aripiprazole versus risperidone for treating children and adolescents with tic disorder: a randomized double blind clinical trial. Child Psychiatry Hum Dev. 2013;45(5):596-603.
10. Yoo HK, Joung YS, Lee JS, Song DH, Lee YS, Kim JW, et al. A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder. J Clin Psychiatry. 2013;74(8):772-80.
11. Ho CS, Chiu NC, Tseng CF, Huang YL. Clinical effectiveness of aripiprazole in short-term treatment of tic disorder in children and adolescents: anaturalistic study. Pediatr Neonatol. 2014;55(1):48-52.
12. Masi G, Gagliano A, Siracusano R, Berloffa S, Calarese T, Ilardo G, et al. Aripiprazole in children with Tourette's disorder and co-morbid attention-deficit/hyperactivity disorder: a 12-week, open-label, preliminary study. J Child Adolesc Psychopharmacol. 2012;22(2):120-5.
13. Bowles TM, Levin GM. Aripiprazole: a new atypical antipsychotic drug. Ann Pharmacother. 2003;37:687-94.
14. Yoo HK, Lee JS, Paik KW, Choi SH, Yoon SJ, Kim JE, et al. Open-label study comparing the efficacy and tolerability of aripiprazole and haloperidol in the treatment of pediatric tic disorders. Eur Child Adolesc Psychiatry. 2011;20(3):127-35.
15. Ghanizadeh A. Systemic review of aripiprazole for the treatment of children and adolescents with tic disorders. Neurosciences (Riyadh). 2012;17(3):200-4.
16. Federowicz VJ, Fombonne E. Metabolic side effects of atypical antipsychotics in children: a literature review. J Psychopharmacol. 2005;19(5):533-50.
17. Yan WW. A review of diagnostic and statistical manual of mental disorder-III. Foreign Medical Sciences (Section of Psychiatry). 1981;6:5-9.
18. Pringsheim T, Marras C. Pimozide for tics in Tourette's syndrome. Cochrane Database Syst Rev. 2009;15(2):1-15.
19. Leckman JF, Towbin KE, Ort SI, et al. Clinical assessment of tic disorder severity. In: Tourette's Syndrome and Tic Disorders. New York, NY: John Wiley& Sons; 1988. p. 55-78.
20. WorId Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders Diagnostic Criteria for Research. Geneva: WHO; 1993.
21. The Branch of Psychiatry of Chinese Medical Association. Chinese Classification and Diagnostic Criteria of Mental Disorders-3 (CCMD-3). Science and Technology Press of Shandong Province. 2001.
22. Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, et al. The Yale global tic severity scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28(4):566-73.
23. Walkup JT, Rosenberg LA, Brown J, Singer HS. The validity of instruments measuring tic severity in Tourette's syndrome. J Am Acad Child Adolesc Psychiatry. 1992;31(3):472-7.
24. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
25. Wang YH, Chen ZM, Wang XS. The efficacy of aripiprazole and tiapride for Tourette disorders in children. Shandong Medical Journal. 2013;53(39):58-9.
26. Liu YY, Chen YH, Chen H, Liu ZS. A control study of aripiprazole and tiapride treatment for tic disorders in children. Chin J Contemp Pediatr. 2010;12(6):421-4.
27. Liu ZS, Chen YH, Zhong YQ, Zou LP, Wang H, Sun D, et al. A multicenter controlled study on aripirazole treatment for children with Tourette syndrome in China. Chin J Pediatr. 2011;49(8):572-6.
28. Cheng ZM, Lei QH. Comparative study of Aripiprazole and Haloperidol in the treatment of tic disorder. Medical Journal of Chinese People's Health. 2012;24(4):402-3.
29. Ren ZB, Jin WD, Wang HQ. A comparative study of aripiprazole and haloperidol treatment for tic disorders in children. Chinese Journal of Nervous and Mental Diseases. 2012;38(4):222-4.
30. Zhao ZL, Guo P, Guo H. The efficacy of aripiprazole and haloperidol treatment for tic disorders in children. World Health Digest Medical Periodieal. 2011;8(29):111-3.
31. Guo F, Qin X, Guo SQ, Li YL. Aripiprazole and haloperidol in the treatment of tic disorder of childhood. China Journal of Health Psychology. 2013;21(12):1767-8.
32. Gao R, Zhou YD, Huang ZY, Tang JH, Lu HP. An open label control study of aripiprazole and haloperidol in the treatment of tic disorder for children. Sichuan Mental Health. 2013;26(4):300-2.
33. Liang YZ, Zhou FC, Zheng Y, Yang JH, Liu J, Wang P, et al. Comparative study of aripiprazole in the treatment of Tourette syndrome. Chinese Journal of Nervous and Mental Disease. 2010;36(2):111-2.
34. Cohen SC, Leckman JF, Bloch MH. Clinical assessment of Tourette syndrome and tic disorders. Neurosci Biobehav Rev. 2013;37(6):997-1007.
35. Waldon K, Hill J, Termine C, Balottin U, Cavanna AE. Trials of pharmacological interventions for Tourette syndrome: a systematic review. Behav Neurol. 2013;26(4):265-73.